Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

May 16, 2011 13:02 ET

PDH Signs Definitive Market Development Partnership Agreement for China

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 16, 2011) -

(NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA)

Premier Diagnostic Health Service Inc. ("PDH") (CNSX:PDH) announced today that, following the signing of a Letter of Intent on March 17, 2011, it has signed a definitive Market Development Partnership Agreement with GeneDiagnostic Inc. of Hangzhou, China. GeneDiagnostic representatives are scheduled to meet with PDH Management shortly to implement the next steps of the Company's marketing plan.

As the representative of products and services of several international companies active in aspects of cancer care in China, GeneDiagnostic has well established relationships with hospitals in Shanghai and surrounding provinces. Partnering with GeneDiagnostic in the PDH Marketing Development Program is part of the PDH strategy designed to quickly identify and realize on opportunities and accelerate completion of Joint Venture Agreements for the establishment and operation of Premier Diagnostic Centres in hospitals.

"The agreement with GeneDiagnostic rounds out our China Market Development Team, together with Leonhard Braunizer, our Director, International Sales and Kathy Su, our Manager, Market Development," said Denis Tusar, CEO of PDH. "The scope of the PDH China 5 Year growth Plan requires a strong on-the-ground team, and with the addition of GeneDiagnostic we have achieved that."

"I am delighted with the way the team has come together," said Leonhard Braunizer. "We now have the bases covered for a successful campaign in China."

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

PDH is engaged in developing and operating diagnostic imaging clinics in Canada and China, with a focus on PET-CT Scanning ("Positron Emission Tomography – Computed Tomography"). PDH is committed to providing the latest technology to enhance health options, and owns and operates the first and only private PET-CT clinic in Western Canada as well as an MRI clinic in collaboration with No. 3 Military Police Hospital in Beijing, China. The Centre for Advanced Diagnostics in Burnaby offers access to the most advanced medical imaging technology available in cancer care today, and is dedicated to meeting today's healthcare needs through delivering exceptional patient care.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release.

Contact Information